Security (S&B/CBRNE) Magazine

Spring 2017

Security & Border Protection and CST & CBRNE Source Book, published jointly, concentrate on WMD response, NGB training, counterterrorism, and border security

Issue link:

Contents of this Issue


Page 24 of 35

Health care providers also need tools – medical countermeasures – at their fingertips. Our Biomedi- cal Advanced Research and Development Authority (BARDA) was established to fill a need for a federal agency that works on the advanced stages of devel- opment to make these medical countermeasures available. They've found innovative ways to partner with the pharmaceutical industry to develop prod- ucts against anthrax; smallpox; botulism; glanders; certain chemicals like inhaled chlorine, mustard gas and nerve agents, and acute radiation injuries. We've also sponsored development of medical counter- measures against diseases that pose national health threats, like Ebola and Zika, and against pandemic influenza viruses, including H5N1 and the newly emerging H7N9 strain. In less than 10 years, we've added 20 products to the Strategic National Stockpile to be available in a national emergency. BARDA's support has helped 23 products achieve approval from the Food and Drug Administration, and some of these products have common medical uses so they don't need to be stockpiled and would be more readily available in a national emergency. The most important consideration in responding to a given threat is to have the right medical countermeasures to the right patient at the right time. To prioritize which medical coun- termeasures to pursue and make the best use of tax dollars, we created a federal coordinating body which we call the Public Health Emergency Medical Countermeasure Enterprise, or PHEMCE. ASPR leads the PHEMCE with representatives from the Departments of Homeland Security, Defense, and Veteran Affairs, FDA, Centers for Disease Control and Prevention, and the National Institutes of Health. Together we move products forward to protect Americans in domestic emergencies. Because of this coordination, medical coun- termeasures in early development with funding from DoD or VA for warfighters or NIH can transition to BARDA for support at advanced stages to become approved and available. CST & CBRNE: From an Infectious Diseases perspective, how is PHEMCE addressing daily routine readiness and contingency preparedness? Dr. Korch: Seeing to the full life cycle management of a medical countermeasure requires tremendous coordination among many federal partners. PHEMCE partners show, day in and day out, that the federal government can be innovative and demonstrate results, and can deliver products with the end users in mind. We now look for medical products that have common medical uses, for example a drug to treat epilepsy that also could work for the spasms caused by chemical exposure or a treatment for cancer radiologic therapy that could be used after a nuclear explosion. Almost every researcher who is funded by the National Institute for Allergy and Infectious Diseases at NIH contacts BARDA in case the In preparation for the annual State of the Union Address, which brings together all leaders from every branch of federal government, National Disaster Medical System personnel drill with local law enforcement and emergency responders to ensure readiness for a nuclear/radiological emergency. (DHHS) NEW TOOL FOR AIRWAY MANAGEMENT Dual-Air TM Adjustable Oral Airway | 1-888-812-7474 | Adjustable Oral Airway DA 200 Pediatric : 50 – 70 mm DA 100 Adult : 70 – 100 mm DA 300 XLg Adult: 80 – 120 mm Non-Gagging: Unconscious Semi-conscious Alert Improved: • Ventilation Port • Suctioning access • Adaptability • Comfort • Stays in Place Simplified: • Selection • Storage • Application • Rapid MCI Response Three Sizes: (Cage Code 6JA31) All with 5 mm half-steps PREPAREDNESS AND RESPONSE EMERGENCY MED COUNTERMEASURES Spring 2017 | S&BP and CST & CBRNE | 23

Articles in this issue

Links on this page

Archives of this issue

view archives of Security (S&B/CBRNE) Magazine - Spring 2017